Analyst Profile

Followed by 662 followers
.
Michael Yee

Michael Yee

Jefferies
Wall Street Analyst
#5,316 out of 8,141 Wall Street Analysts
#15,218 out of 24,284 experts

Success Rate

46%
164 out of 357 transactions made a profit

Average Return

-0.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Michael Yee's trades since 2012 and holding each position for 1 Year would result in 45.94% of your transactions generating a profit, with an average return of -0.1% per rating.

Stock Rating Distribution

1KRatings
83.05% Buy
16.54% Hold
0.41% Sell
Distribution of Michael Yee's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Beam Therapeutics, Inc.
(BEAM)
Rating:Buy
Date:Mar 02, 2020 - Mar 02, 2021
Return:+300.90%
The most profitable rating made by Michael Yee

Michael Yee's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Myrexis
Mar 20, 2012
Buy
Reiterated
$28.00
(5599900.00% Upside)
2Ratings
0.00%
Oracle
Jun 29, 2012
Buy
Upgraded
1Ratings
0.00%
Uni-Pixel
Dec 10, 2012
Buy
Reiterated
1Ratings
0.00%
ELN
Elan Corp
Jun 10, 2013
Hold
Reiterated
3Ratings
0.00%
ASTX
Astex Pharmaceuticals
Aug 28, 2013
Buy
Reiterated
3Ratings
0.00%
DNDNQ
Dendreon Corp
Aug 28, 2013
Hold
Reiterated
2Ratings
0.00%
Myriad Genetics
Jun 30, 2014
Hold
Assigned
$40.00
(108.66% Upside)
4Ratings
0.00%
ITMN
InterMune
Aug 29, 2014
Hold
Assigned
3Ratings
0.00%
AUXL
Auxilium
Sep 24, 2014
Hold
Downgraded
9Ratings
0.00%
PCYC
Pharmacyclics
Mar 05, 2015
Hold
Reiterated
13Ratings
0.00%
List of latest recommendations made by Michael Yee. Click to expand and see Michael Yee's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >